Literature DB >> 11306353

A small molecule designed to bind to the adenine nucleotide pocket of Hsp90 causes Her2 degradation and the growth arrest and differentiation of breast cancer cells.

G Chiosis1, M N Timaul, B Lucas, P N Munster, F F Zheng, L Sepp-Lorenzino, N Rosen.   

Abstract

BACKGROUND: The Hsp90s contain a conserved pocket that binds ATP/ADP and plays an important role in the regulation of chaperone function. Occupancy of this pocket by several natural products (geldanamycin (GM) and radicicol) alters Hsp90 function and results in the degradation of a subset of proteins (i.e. steroid receptors, Her2, Raf). We have used the structural features of this pocket to design a small molecule inhibitor of Hsp90.
RESULTS: The designed small molecule PU3 competes with GM for Hsp90 binding with a relative affinity of 15-20 microM. PU3 induces degradation of proteins, including Her2, in a manner similar to GM. Furthermore, PU3 inhibits the growth of breast cancer cells causing retinoblastoma protein hypophosphorylation, G1 arrest and differentiation.
CONCLUSIONS: PU3 is representative of a novel class of synthetic compounds that binds to Hsp90 and inhibits the proliferation of cancer cells. These reagents could provide a new strategy for the treatment of cancers.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11306353     DOI: 10.1016/s1074-5521(01)00015-1

Source DB:  PubMed          Journal:  Chem Biol        ISSN: 1074-5521


  63 in total

1.  Advances in the discovery and development of heat-shock protein 90 inhibitors for cancer treatment.

Authors:  Hardik J Patel; Shanu Modi; Gabriela Chiosis; Tony Taldone
Journal:  Expert Opin Drug Discov       Date:  2011-05       Impact factor: 6.098

2.  Paralog-selective Hsp90 inhibitors define tumor-specific regulation of HER2.

Authors:  Pallav D Patel; Pengrong Yan; Paul M Seidler; Hardik J Patel; Weilin Sun; Chenghua Yang; Nanette S Que; Tony Taldone; Paola Finotti; Ralph A Stephani; Daniel T Gewirth; Gabriela Chiosis
Journal:  Nat Chem Biol       Date:  2013-09-01       Impact factor: 15.040

Review 3.  Advances in the clinical development of heat shock protein 90 (Hsp90) inhibitors in cancers.

Authors:  Komal Jhaveri; Tony Taldone; Shanu Modi; Gabriela Chiosis
Journal:  Biochim Biophys Acta       Date:  2011-10-29

Review 4.  A Chemical Biology Approach to the Chaperome in Cancer-HSP90 and Beyond.

Authors:  Tony Taldone; Tai Wang; Anna Rodina; Naga Vara Kishore Pillarsetty; Chander S Digwal; Sahil Sharma; Pengrong Yan; Suhasini Joshi; Piyusha P Pagare; Alexander Bolaender; Gail J Roboz; Monica L Guzman; Gabriela Chiosis
Journal:  Cold Spring Harb Perspect Biol       Date:  2020-04-01       Impact factor: 10.005

5.  Microwave-assisted one step synthesis of 8-arylmethyl-9H-purin-6-amines.

Authors:  Hui Tao; Yanlong Kang; Tony Taldone; Gabriela Chiosis
Journal:  Bioorg Med Chem Lett       Date:  2008-11-20       Impact factor: 2.823

Review 6.  Apoptosis versus cell differentiation: role of heat shock proteins HSP90, HSP70 and HSP27.

Authors:  David Lanneau; Aurelie de Thonel; Sebastien Maurel; Celine Didelot; Carmen Garrido
Journal:  Prion       Date:  2007-01-24       Impact factor: 3.931

Review 7.  Chaperome heterogeneity and its implications for cancer study and treatment.

Authors:  Tai Wang; Anna Rodina; Mark P Dunphy; Adriana Corben; Shanu Modi; Monica L Guzman; Daniel T Gewirth; Gabriela Chiosis
Journal:  J Biol Chem       Date:  2018-11-08       Impact factor: 5.157

8.  Divergent synthesis of a pochonin library targeting HSP90 and in vivo efficacy of an identified inhibitor.

Authors:  Sofia Barluenga; Cuihua Wang; Jean-Gonzague Fontaine; Kaïss Aouadi; Kristin Beebe; Shinji Tsutsumi; Len Neckers; Nicolas Winssinger
Journal:  Angew Chem Int Ed Engl       Date:  2008       Impact factor: 15.336

Review 9.  New developments in Hsp90 inhibitors as anti-cancer therapeutics: mechanisms, clinical perspective and more potential.

Authors:  Yanyan Li; Tao Zhang; Steven J Schwartz; Duxin Sun
Journal:  Drug Resist Updat       Date:  2009 Feb-Apr       Impact factor: 18.500

10.  An AlphaScreen-based high-throughput screen to identify inhibitors of Hsp90-cochaperone interaction.

Authors:  Fang Yi; Pingjun Zhu; Noel Southall; James Inglese; Christopher P Austin; Wei Zheng; Lynne Regan
Journal:  J Biomol Screen       Date:  2009-02-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.